OCEF1_LEPLB
ID OCEF1_LEPLB Reviewed; 25 AA.
AC C0HKF0; A0A1W2VMZ4;
DT 10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT 10-MAY-2017, sequence version 1.
DT 25-MAY-2022, entry version 12.
DE RecName: Full=Ocellatin-F1 {ECO:0000303|PubMed:26635873, ECO:0000303|PubMed:28115922};
DE Short=OF1 {ECO:0000303|PubMed:26635873, ECO:0000303|PubMed:28115922};
DE AltName: Full=Fallaxin {ECO:0000250|UniProtKB:P0DQJ8};
OS Leptodactylus labyrinthicus (Labyrinth frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Neobatrachia; Hyloidea; Leptodactylidae; Leptodactylinae;
OC Leptodactylus.
OX NCBI_TaxID=326590;
RN [1]
RP PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY.
RC TISSUE=Skin secretion;
RX PubMed=26635873; DOI=10.1186/s40409-015-0048-1;
RA Cunha Neto Rdos S., Vigerelli H., Jared C., Antoniazzi M.M., Chaves L.B.,
RA da Silva Ade C., Melo R.L., Sciani J.M., Pimenta D.C.;
RT "Synergic effects between ocellatin-F1 and bufotenine on the inhibition of
RT BHK-21 cellular infection by the rabies virus.";
RL J. Venom. Anim. Toxins Incl. Trop. Dis. 21:50-50(2015).
RN [2]
RP PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MASS SPECTROMETRY, AND
RP AMIDATION AT LEU-25.
RC TISSUE=Skin secretion;
RX PubMed=28115922; DOI=10.1186/s40409-017-0094-y;
RA Gusmao K.A., Dos Santos D.M., Santos V.M., Cortes M.E., Reis P.V.,
RA Santos V.L., Pilo-Veloso D., Verly R.M., de Lima M.E., Resende J.M.;
RT "Ocellatin peptides from the skin secretion of the South American frog
RT Leptodactylus labyrinthicus (Leptodactylidae): characterization,
RT antimicrobial activities and membrane interactions.";
RL J. Venom. Anim. Toxins Incl. Trop. Dis. 23:4-4(2017).
RN [3] {ECO:0007744|PDB:5U9S, ECO:0007744|PDB:5U9Y, ECO:0007744|PDB:5UA8}
RP STRUCTURE BY NMR IN PRESENCE OF ANIONIC SDS MICELLES; ZWITTERIONIC DPC
RP MICELLES AND TFE:H2O SOLUTION.
RX PubMed=29596881; DOI=10.1016/j.peptides.2018.03.016;
RA Gomes K.A.G.G., Dos Santos D.M., Santos V.M., Pilo-Veloso D., Mundim H.M.,
RA Rodrigues L.V., Liao L.M., Verly R.M., de Lima M.E., Resende J.M.;
RT "NMR structures in different membrane environments of three ocellatin
RT peptides isolated from Leptodactylus labyrinthicus.";
RL Peptides 103:72-83(2018).
CC -!- FUNCTION: Antibacterial peptide that inhibits reference strains of both
CC Gram-negative bacteria (E.coli, P.aeruginosa, E.cloacae, K.pneumoniae,
CC and A.actinomycetemcomitans) and Gram-positive bacteria (S.aureus) with
CC relatively low potencies (MIC=25-400 uM) (PubMed:28115922) (By
CC similarity). Shows antifungal activity against C.lusitaniae (MIC=50.25
CC uM), but no activity against C.albicans (PubMed:28115922). In the
CC presence of an alkaloid (bufotenine), inhibits cellular infection by
CC the rabies virus (PubMed:26635873). The peptide shows very low
CC hemolytic activity against rabbit erythrocytes (PubMed:28115922) (By
CC similarity). The low amphipathicity of alpha-helices demonstrated by
CC wheel projection as well as the low cationicity may explain the low
CC antibacterial and hemolytic potencies (By similarity).
CC {ECO:0000250|UniProtKB:P0DQJ8, ECO:0000269|PubMed:26635873,
CC ECO:0000269|PubMed:28115922}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:26635873,
CC ECO:0000269|PubMed:28115922}.
CC -!- TISSUE SPECIFICITY: Expressed by the skin glands.
CC {ECO:0000305|PubMed:26635873, ECO:0000305|PubMed:28115922}.
CC -!- MASS SPECTROMETRY: Mass=2547.98; Method=Electrospray;
CC Evidence={ECO:0000269|PubMed:26635873};
CC -!- MASS SPECTROMETRY: Mass=2546.52; Mass_error=0.012; Method=MALDI;
CC Evidence={ECO:0000269|PubMed:28115922};
CC -!- MISCELLANEOUS: The primary structure of this peptide is identical to
CC that of Ocellatin-F1 from Leptodactylus fallax (AC P0DQJ8).
CC {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the frog skin active peptide (FSAP) family.
CC Ocellatin subfamily. {ECO:0000305}.
CC -!- WEB RESOURCE: Name=The antimicrobial peptide database;
CC URL="https://wangapd3.com/database/query_output.php?ID=00533";
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR PDB; 5U9S; NMR; -; A=1-25.
DR PDB; 5U9Y; NMR; -; A=1-24.
DR PDB; 5UA8; NMR; -; A=1-25.
DR PDBsum; 5U9S; -.
DR PDBsum; 5U9Y; -.
DR PDBsum; 5UA8; -.
DR AlphaFoldDB; C0HKF0; -.
DR SMR; C0HKF0; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR GO; GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW.
DR GO; GO:0019836; P:hemolysis by symbiont of host erythrocytes; IEA:InterPro.
DR GO; GO:0031640; P:killing of cells of another organism; IEA:UniProtKB-KW.
DR GO; GO:0050688; P:regulation of defense response to virus; IEA:UniProtKB-KW.
DR InterPro; IPR012518; Antimicrobial15.
DR Pfam; PF08110; Antimicrobial15; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Amidation; Amphibian defense peptide; Antibiotic;
KW Antimicrobial; Antiviral protein; Direct protein sequencing; Fungicide;
KW Secreted.
FT PEPTIDE 1..25
FT /note="Ocellatin-F1"
FT /evidence="ECO:0000269|PubMed:26635873,
FT ECO:0000269|PubMed:28115922"
FT /id="PRO_0000439884"
FT MOD_RES 25
FT /note="Leucine amide"
FT /evidence="ECO:0000269|PubMed:28115922"
FT HELIX 3..24
FT /evidence="ECO:0007829|PDB:5U9S"
SQ SEQUENCE 25 AA; 2549 MW; 3C42EAC8DE570755 CRC64;
GVVDILKGAA KDIAGHLASK VMNKL